Friday, January 30, 2026 | 11:48 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Chronic Pain

What is CRPS? The rare pain disorder affecting Archana Puran Singh

Often mistaken for slow recovery, CRPS is a chronic pain disorder that can be life-altering. The actor's experience highlights why awareness matters

What is CRPS? The rare pain disorder affecting Archana Puran Singh
Updated On : 22 Jan 2026 | 6:39 PM IST

Stem cell therapy: How Abhay Deol found relief from chronic pain

After years of knee pain and sciatica, the actor turned to stem cell therapy, fuelling curiosity around regenerative treatments and what doctors say about safety and evidence

Stem cell therapy: How Abhay Deol found relief from chronic pain
Updated On : 22 Jan 2026 | 6:30 PM IST

How hydrotherapy is helping Archana Puran Singh manage a rare pain disorder

From easing stiffness to improving circulation, hydrotherapy is becoming an important part of comprehensive care for people living with chronic pain

How hydrotherapy is helping Archana Puran Singh manage a rare pain disorder
Updated On : 19 Jan 2026 | 2:50 PM IST

Chronic pain could be a hidden driver of high blood pressure, says study

Researchers say widespread or long-term pain may be a major yet overlooked risk factor for hypertension, calling for better pain care and routine blood pressure checks

Chronic pain could be a hidden driver of high blood pressure, says study
Updated On : 18 Nov 2025 | 2:24 PM IST

Zydus gets USFDA approval for a high blood pressure to treat angina

Zydus Lifesciences on Monday said it has received approval from the US health regulator to market a drug used to treat angina and high blood pressure. The company has received final approval from the US Food and Drug Administration (USFDA) for Diltiazem Hydrochloride tablets in strengths of 30 mg, 60 mg, 90 mg, and 120 mg, the drug maker said in a statement. Diltiazem Hydrochloride Tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm. It belongs to a class of drugs called calcium-channel blockers. Diltiazem works by relaxing blood vessels, which reduces the workload on the heart and increases blood and oxygen supply to the heart muscle. The company said Diltiazem Hydrochloride Tablets will be produced at Zydus Lifesciences' Baddi plant in Himachal Pradesh. As per IQVIA MAT June 2025 data, Diltiazem Hydrochloride Tablets had annual sales of USD 13.9 million in the US.

Zydus gets USFDA approval for a high blood pressure to treat angina
Updated On : 11 Aug 2025 | 2:18 PM IST

Suffering from chronic pain? Cut monosodium glutamate from your diet

The results demonstrated that when participants cut monosodium glutamate from their diets, their symptoms improved

Suffering from chronic pain? Cut monosodium glutamate from your diet
Updated On : 17 Feb 2018 | 9:40 PM IST